Silo Pharma Inc. is set to hold its 2025 Annual Meeting of Stockholders on October 24, 2025, at its office in Sarasota, Florida. The meeting will address several key proposals, including the election of the Board's director nominees, the approval of the First Amendment to the Silo Pharma, Inc. Amended and Restated 2020 Omnibus Equity Incentive Plan, and the authorization of the adjournment of the meeting if necessary to solicit additional proxies. The meeting will also cover the ratification of the appointment of Salberg as the independent registered public accounting firm for the company.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Silo Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-085119), on September 05, 2025, and is solely responsible for the information contained therein.